Placebo controls in clinical trials of new therapies for osteoporosis.

Suppr

超能文献

作者信息

Levine Robert J

机构信息

Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

J Bone Miner Res. 2003 Jun;18(6):1154-9. doi: 10.1359/jbmr.2003.18.6.1154.

DOI:10.1359/jbmr.2003.18.6.1154

PMID:12817775

Abstract

摘要

相似文献

Placebo controls in clinical trials of new therapies for osteoporosis.

J Bone Miner Res. 2003 Jun;18(6):1154-9. doi: 10.1359/jbmr.2003.18.6.1154.

Osteoporosis panel summary.

J Bone Miner Res. 2003 Jun;18(6):1160-2. doi: 10.1359/jbmr.2003.18.6.1160.

Study design in osteoporosis: a European perspective.

J Bone Miner Res. 2003 Jun;18(6):1133-8. doi: 10.1359/jbmr.2003.18.6.1133.

Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.

J Bone Miner Res. 2003 Jun;18(6):1142-5. doi: 10.1359/jbmr.2003.18.6.1142.

Study designs in osteoporosis.

J Bone Miner Res. 2003 Jun;18(6):1129-32. doi: 10.1359/jbmr.2003.18.6.1129.

Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?

J Bone Miner Res. 2003 Jun;18(6):1105-9. doi: 10.1359/jbmr.2003.18.6.1105.

The ethics of placebo-controlled trials.

J Bone Miner Res. 2003 Jun;18(6):1150-3. doi: 10.1359/jbmr.2003.18.6.1150.

A clinical perspective on placebo research: looking back, looking forward.

Am J Bioeth. 2009 Sep;9(9):54-5. doi: 10.1080/15265160903090108.

Ethics and science of placebo-controlled trials.

J Psychopharmacol. 2008 Aug;22(6):598-9. doi: 10.1177/0269881107083807. Epub 2008 Feb 28.

Research, medicine, and "placebos".

Am J Bioeth. 2009 Sep;9(9):64-5. doi: 10.1080/15265160903090090.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Placebo controls in clinical trials of new therapies for osteoporosis.

J Bone Miner Res. 2003 Jun;18(6):1154-9. doi: 10.1359/jbmr.2003.18.6.1154.

Osteoporosis panel summary.

J Bone Miner Res. 2003 Jun;18(6):1160-2. doi: 10.1359/jbmr.2003.18.6.1160.

Study design in osteoporosis: a European perspective.

J Bone Miner Res. 2003 Jun;18(6):1133-8. doi: 10.1359/jbmr.2003.18.6.1133.

Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.

J Bone Miner Res. 2003 Jun;18(6):1142-5. doi: 10.1359/jbmr.2003.18.6.1142.

Study designs in osteoporosis.

J Bone Miner Res. 2003 Jun;18(6):1129-32. doi: 10.1359/jbmr.2003.18.6.1129.

Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?

J Bone Miner Res. 2003 Jun;18(6):1105-9. doi: 10.1359/jbmr.2003.18.6.1105.

The ethics of placebo-controlled trials.

J Bone Miner Res. 2003 Jun;18(6):1150-3. doi: 10.1359/jbmr.2003.18.6.1150.

A clinical perspective on placebo research: looking back, looking forward.

Am J Bioeth. 2009 Sep;9(9):54-5. doi: 10.1080/15265160903090108.

Ethics and science of placebo-controlled trials.

J Psychopharmacol. 2008 Aug;22(6):598-9. doi: 10.1177/0269881107083807. Epub 2008 Feb 28.

Research, medicine, and "placebos".

Am J Bioeth. 2009 Sep;9(9):64-5. doi: 10.1080/15265160903090090.